Variant report
Variant | nsv982152 |
---|---|
Chromosome Location | chr8:113261900-113265476 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10096605 | chr8:113261958-113261959 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs532364309 | chr8:113261960-113261961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs34992590 | chr8:113262011-113262012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs16883301 | chr8:113262032-113262033 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs369246990 | chr8:113262082-113262083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs373744016 | chr8:113262090-113262091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538514767 | chr8:113262123-113262124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs372519464 | chr8:113262220-113262221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554782986 | chr8:113262260-113262261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79446459 | chr8:113262274-113262275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551490449 | chr8:113262514-113262515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571643333 | chr8:113262526-113262527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568311993 | chr8:113262555-113262556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7846229 | chr8:113262733-113262734 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs553409276 | chr8:113262746-113262747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190941359 | chr8:113262766-113262767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369774032 | chr8:113262860-113262861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576786990 | chr8:113262874-113262875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545451448 | chr8:113262908-113262909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554489823 | chr8:113262915-113262916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574313248 | chr8:113262916-113262917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536444759 | chr8:113262949-113262950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183176318 | chr8:113263110-113263111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576295562 | chr8:113263153-113263154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556265920 | chr8:113263173-113263174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186745982 | chr8:113263244-113263245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561912471 | chr8:113263296-113263297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7816045 | chr8:113263301-113263302 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs540740741 | chr8:113263346-113263347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs16883307 | chr8:113263374-113263375 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs532561466 | chr8:113263379-113263380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552318206 | chr8:113263424-113263425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111782826 | chr8:113263449-113263450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536698270 | chr8:113263463-113263464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs376215015 | chr8:113263477-113263478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569225705 | chr8:113263489-113263490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111354515 | chr8:113263497-113263498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs531928413 | chr8:113263500-113263501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35940162 | chr8:113263570-113263571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191276815 | chr8:113263642-113263643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs370829626 | chr8:113263664-113263665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534090842 | chr8:113263731-113263732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553470720 | chr8:113263734-113263735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570478048 | chr8:113263735-113263736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539501883 | chr8:113263755-113263756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555929140 | chr8:113263768-113263769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570077763 | chr8:113263808-113263809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535753472 | chr8:113263848-113263849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184946022 | chr8:113263933-113263934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572286818 | chr8:113263934-113263935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Schizophrenia | 20967226 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:113235200-113265400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr8:113259400-113266800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr8:113263400-113265600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr8:113264400-113264600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr8:113264400-113264800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr8:113264400-113264800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr8:113264400-113269200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr8:113264600-113265200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr8:113264600-113268600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr8:113264800-113265200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr8:113264800-113265200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr8:113265200-113265600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr8:113265200-113266200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr8:113265200-113266600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr8:113265200-113268800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
16 | chr8:113265200-113269000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr8:113265400-113266200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr8:113265400-113266200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
19 | chr8:113265400-113266200 | Enhancers | NHEK | skin |
20 | chr8:113265400-113268800 | Enhancers | HUES6 Cell Line | embryonic stem cell |